Wuhan, Hubei 430022
China
Huazhong University of Science and Technology - Department of Pharmacy
COVID-19, Survivor, Non-survivor, Independent predictor of mortality, nomagram
bevacizumab, safety, economic evaluation, PD-1 inhibitors, advanced non-squamous NSCLC